סימבקסון 40
dexcel pharma technologies ltd - simvastatin - קפליות - simvastatin 40 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvaxon is indicated to: - reduce the risk of total mortality by reducing coronary death - reduce the risk of non-fatal myocardial infarction - reduce the risk for undergoing myocardial revascularization procedures - reduce the risk of stroke and transient ischemic attacks (tia's). hyperlipidemia: simvaxon is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvaxon therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hype
אוורה
trima israel pharmaceutical products maabarot ltd - ethinylestradiol; norelgestromin - מדבקות - norelgestromin 6 mg; ethinylestradiol 0.6 mg - norelgestromin and estrogen - norelgestromin and estrogen - female contraception. evra is intended for women of fertile age.
אלפו-קל xl
padagis israel agencies ltd, israel - alfuzosin hydrochloride - טבליות בשחרור ממושך - alfuzosin hydrochloride 10 mg - alfuzosin - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason.
קמראב
kamada ltd, israel - human-rabies immunoglobulin - תמיסה להזרקה - human-rabies immunoglobulin 150 iu/ml - rabies immunoglobulin - rabies immunoglobulin - kamrab im is indicated for passive, transient post-exposure prevention of rabies infection when given immediately to individuals in cases of contact with rabid or possibly rabid animal.
אבסטרל 100 מק"ג
neopharm ltd - fentanyl as citrate 100 mcg - tablets sublingual - fentanyl - management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.
אבסטרל 200 מק"ג
neopharm ltd - fentanyl as citrate 200 mcg - tablets sublingual - fentanyl - management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.
אבסטרל 300 מק"ג
neopharm ltd - fentanyl as citrate 300 mcg - tablets sublingual - fentanyl - management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.
אבסטרל 400 מק"ג
neopharm ltd - fentanyl as citrate 400 mcg - tablets sublingual - fentanyl - management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.
אבסטרל 600 מק"ג
neopharm ltd - fentanyl as citrate 600 mcg - tablets sublingual - fentanyl - management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.
אבסטרל 800 מק"ג
neopharm ltd - fentanyl as citrate 800 mcg - tablets sublingual - fentanyl - management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.